✦ LIBER ✦

Early virologic response to treatment with peginterferon alfa-2b plus ribavirin in patients with chronic hepatitis C

✍ Scribed by Gary L. Davis; John B. Wong; John G. McHutchison; Michael P. Manns; Joann Harvey; Janice Albrecht

Book ID: 111722358
Publisher: John Wiley and Sons
Year: 2003
Tongue: English
Weight: 129 KB
Volume: 38
Category: Article
ISSN: 0270-9139
DOI: 10.1053/jhep.2003.50364

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Early virologic response after peginterf

Early virologic response after peginterferon alpha-2a plus ribavirin or peginterferon alpha-2b plus ribavirin treatment in patients with chronic hepatitis C

✍ A. M. Di Bisceglie; R. H. Ghalib; F. M. Hamzeh; V. K. Rustgi 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 547 KB

Peginterferon alfa-2b plus ribavirin tre

Peginterferon alfa-2b plus ribavirin treatment in children and adolescents with chronic hepatitis C

✍ Stefan Wirth; Heidrun Pieper-Boustani; Thomas Lang; Antje Ballauff; Ulrike Kullm 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 107 KB 👁 2 views

Peginterferon plus ribavirin is standard therapy for adults with chronic hepatitis C. As no data are available for children, the aim of the study was to evaluate the efficacy and tolerability of peginterferon alfa-2b in combination with ribavirin in chronically infected children. Genotypes, alanine

Predicting sustained virological respons

Predicting sustained virological response and anaemia in chronic hepatitis C patients treated with peginterferon alfa-2a (40KD) plus ribavirin

✍ Eric Snoeck; Janet R. Wade; Frank Duff; Matthew Lamb; Karin Jorga 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 739 KB

Peginterferon alfa-2a/ribavirin in hepat

Peginterferon alfa-2a/ribavirin in hepatitis C virus patients nontolerant or nonresponsive to peginterferon alfa-2b/ribavirin

✍ V. K. RUSTGI; S. ESPOSITO; F. M. HAMZEH; M. L. SHIFFMAN 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 87 KB

Treatment with peginterferon plus ribavi

Treatment with peginterferon plus ribavirin vs. interferon plus ribavirin for 48 weeks in Chinese patients with chronic hepatitis C

✍ S.-H. Zhao; Y.-L. Chu; D.-X. Cheng; A. B. Waqar; Q. Yu; P.-H. Yang; X. Xue; H.-J 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 203 KB

Prediction of response to peginterferon-

Prediction of response to peginterferon-alfa-2b plus ribavirin therapy in Japanese patients infected with hepatitis C virus genotype 1b

✍ Yoshimasa Hashimoto; Hidenori Ochi; Hiromi Abe; Yasufumi Hayashida; Masataka Tsu 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 174 KB 👁 1 views

## Abstract Variation at the IL‐28B locus was recently reported to be a significant predictive factor of viral response to pegylated‐interferon plus ribavirin combination therapy against chronic hepatitis C. Predictive factors for the effect of therapy, including IL‐28B polymorphism rs8099917 and v